REVANCE THERAPEUTICS, INC.
Matched from indexed company URL: Revance Therapeutics, Inc.
FDA Registration(s)#
Registration, FEI, Name table| Registration | FEI | Name | Status | Initial importer | Expiration year | Address |
|---|
| 3007772056 | 3007772056 | REVANCE THERAPEUTICS, INC. | 1 | Y | 2026-01-01 | 7555 Gateway Blvd Newark CA US 94560 |
Registered Device Listings#
Registration key, Listing key, Premarket submission table| Registration key | Listing key | Premarket submission | Device | Product code | Decision date |
|---|
| 238121 | 1098688883 | P170002 | RHA 2, RHA 3, RHA 4 | LMH | 2017-10-19 |
Product Codes Associated With Registrations#
Product code, Registration listing records, Latest decision table| Product code | Registration listing records | Latest decision |
|---|
| LMH | 1 | 2017-10-19 |
NDC#
Revance Therapeutics, Inc.
botulinum toxin type A
Applications#
REVANCE THERAPEUTICS, INC.